ARTICLE | Clinical News
Betatropin: Phase II
September 17, 2001 7:00 AM UTC
Restoragen said subcutaneous infusion of Betatropin improved blood glucose levels in Type II diabetics over a 7 day infusion period compared to placebo. Results of the 47 patient, double-blind, dose-r...